These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12534456)

  • 1. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist.
    Mastalerz L; Nizankowska E; Sanak M; Mejza F; Pierzchalska M; Bazan-Socha S; Bestynska-Krypel A; Cmiel A; Szczeklik A
    Eur J Clin Invest; 2002 Dec; 32(12):949-55. PubMed ID: 12534456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
    Mastalerz L; Gawlewicz-Mroczka A; Nizankowska E; Cmiel A; Szczeklik A
    Clin Exp Allergy; 2002 Sep; 32(9):1360-5. PubMed ID: 12220476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
    Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
    J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.
    Ragab S; Parikh A; Darby YC; Scadding GK
    Clin Exp Allergy; 2001 Sep; 31(9):1385-91. PubMed ID: 11591188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
    Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene E
    Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
    J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.
    Cai C; Yang J; Hu S; Zhou M; Guo W
    Lung; 2007; 185(2):105-12. PubMed ID: 17393242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
    Pizzichini E; Leff JA; Reiss TF; Hendeles L; Boulet LP; Wei LX; Efthimiadis AE; Zhang J; Hargreave FE
    Eur Respir J; 1999 Jul; 14(1):12-8. PubMed ID: 10489822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
    Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
    Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
    Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
    Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
    Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
    J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.